Cargando…
Accuracy of FGF‐21 and GDF‐15 for the diagnosis of mitochondrial disorders: A meta‐analysis
OBJECTIVE: Given their diverse phenotypes, mitochondrial diseases (MDs) are often difficult to diagnose. Fibroblast growth factor 21 (FGF‐21) and growth differentiation factor 15 (GDF‐15) represent promising biomarkers for MD diagnosis. Herein we conducted a meta‐analysis to compare their diagnostic...
Autores principales: | Lin, Yan, Ji, Kunqian, Ma, Xiaotian, Liu, Shuangwu, Li, Wei, Zhao, Yuying, Yan, Chuanzhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359119/ https://www.ncbi.nlm.nih.gov/pubmed/32585080 http://dx.doi.org/10.1002/acn3.51104 |
Ejemplares similares
-
Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders
por: Peñas, Ana, et al.
Publicado: (2021) -
Circulating FGF21 and GDF15 as Biomarkers for Screening, Diagnosis, and Severity Assessment of Primary Mitochondrial Disorders in Children
por: Li, Yi, et al.
Publicado: (2022) -
The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine
por: Burow, Philipp, et al.
Publicado: (2021) -
The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response
por: Jena, Jayashree, et al.
Publicado: (2023) -
Differential roles of GDF15 and FGF21 in systemic metabolic adaptation to the mitochondrial integrated stress response
por: Kang, Seul Gi, et al.
Publicado: (2021)